North America, Europe, and Australia Peanut Allergy Treatment Market, By Drug Type, By Route of Administration, By Distribution Channel, By Geography

Description

North America, Europe, and Australia Peanut Allergy Treatment Market is estimated to be valued at USD 1,345.8 Mn in 2026 and is expected to reach USD 1,876.4 Mn by 2033, growing at a compound annual growth rate (CAGR) of 12.3% from 2026 to 2033.

Report Coverage		Report Details
Base Year:	2025	Market Size in 2026:	USD 1,345.8 Mn
Historical Data for:	2020 To 2024	Forecast Period:	2026 To 2033
Forecast Period 2026 to 2033 CAGR:	12.30%	2033 Value Projection:	USD 1,876.4 Mn

Peanut allergy is an allergic response by individual on exposure to peanuts. The most severe allergic reaction to peanuts is anaphylaxis a life-threatening whole-body response to an allergen. Anaphylaxis should be treated immediately with epinephrine (adrenaline), typically administered in an auto-injector. Diagnosing a peanut allergy can be complicated. Symptoms can vary from person to person, and a single individual may not always experience the same symptoms during every reaction.

Market Dynamics

Key players operating in the North America, Europe, and Australia peanut allergy treatment market are focusing on adoption of growth strategies such as product approval for the treatment of peanut allergy which are expected to drive market growth during the forecast period. For instance, In September 2021, COUR Pharmaceuticals, a pharmaceutical company, announced that the U.S. Food and Drug Administration (FDA) accepted the company's Investigational New Drug (IND) application for evaluation of COUR's CNP-201 in a proof-of-concept (Phase 1 / 2) study in people who are allergic to peanuts. Moreover, increasing adoption of inorganic growth strategies by market players and government organizations is expected to drive the market growth over the forecast period. For instance, in December 2021, the National Health Service, U.K., announced that the department of health signed an agreement with Aimmune Therapeutics, Inc., a Nestle Health Science company to provide Palforzia in the U.K. The U.K. will be the first country to receive Palforzia in Europe.

Key features of the study

This report provides in-depth analysis of the North America, Europe, and Australia peanut allergy treatment market, and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2022-2030), considering 2021 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the North America, Europe, and Australia peanut allergy treatment market based on the following parameters - Company Highlights, Products Portfolio, Key Highlights, Financial Performance, and Strategies
Key companies covered as a part of this study include, DBV Technologies DBV Technologies, Aimmune Therapeutics, Inc., Prota Therapeutics Pty Ltd., COUR Pharmaceuticals, BlueWillow Biologics, HAL Allergy B.V., Allergy Therapeutics PLC., Novartis AG, Regeneron Pharmaceuticals, Inc., Vedanta Biosciences, Inc., Cambridge Allergy Ltd. (Camallergy), Angany Inc., Moonlight Therapeutics Inc., Allero Therapeutics B.V., Sanofi, Johnson & Johnson, Viatris Inc. (Mylan N.V.), Sun Pharmaceutical Industries Ltd., Bayer AG, Aurobindo Pharma Limited., Astellas Pharma Inc., Siolta Therapeutics, DESENTUM OY, ALK, Immunomic Therapeutics, Inc., and Stallergenes Greer Ltd.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The North America, Europe, and Australia peanut allergy treatment market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the North America, Europe, and Australia peanut allergy treatment market.

Market Segmentation

By Drug Type
- Epinephrine
- Antihistamine
- Loratadine
- Diphenhydramine
- Others
- Palforzia
- Pipeline Drugs
- Viaskin Peanut
- Ligelizumab
- CA002
- PRT120
- Dupilumab
By Route of Administration
- Oral
- Parenteral
- Intranasal
- Epicutaneous
By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Regional Insights
- North America
- U.S.
- Canada
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Australia
Key Players Insights
- DBV Technologies
- Aimmune Therapeutics, Inc.
- Prota Therapeutics Pty Ltd.
- COUR Pharmaceuticals
- BlueWillow Biologics
- HAL Allergy B.V.
- Allergy Therapeutics PLC.
- Novartis AG
- Regeneron Pharmaceuticals, Inc.
- Vedanta Biosciences, Inc.
- Cambridge Allergy Ltd. (Camallergy)
- Angany Inc.
- Moonlight Therapeutics Inc.
- Allero Therapeutics B.V.
- Sanofi
- Johnson & Johnson
- Viatris Inc. (Mylan N.V.)
- Sun Pharmaceutical Industries Ltd.
- Bayer AG
- Aurobindo Pharma Limited.
- Astellas Pharma Inc.
- Siolta Therapeutics
- DESENTUM OY
- ALK
- Immunomic Therapeutics, Inc.
- Stallergenes Greer Ltd.

Product Code: CMI5041

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Drug Type
- Market Snapshot, By Route of Administration
- Market Snapshot, By Distribution Channels
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Opportunity
Impact Analysis
Key developments
Pipeline Analysis
Collaborations and Agreements
Market Trends
Product Approval
Regulatory Scenario
PEST Analysis
PORTER's Five Forces Analysis
Reimbursement Scenario
Prescriber Preference: Overview
Prescriber Overview
Treatment Algorithm
Epidemiology

4. North America Europe and Australia Peanut Allergy Treatment Market, By Drug Type, 2026-2033, (USD Mn)

Introduction
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2020-2033
- Segment Trends
Epinephrine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2033,(USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, 2020-2033,(USD Mn)
Antihistamine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2033,(USD Mn)
  - Loratadine
  - Diphenhydramine
  - Others
- Palforzia
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2020-2033,(USD Mn)
- Pipeline Drugs
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2020-2033,(USD Mn)
    - Viaskin Peanut
    - Ligelizuma
    - CA002
    - PRT120
    - Dupilumab

5. North America Europe and Australia Peanut Allergy Treatment Market, By Route of Administration, 2026-2033, (USD Mn)

Introduction
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2020-2033
- Segment Trends
Oral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2033,(USD Mn)
Parenteral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2033,(USD Mn)
Intranasal
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2033,(USD Mn)
Epicutaneous
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2033,(USD Mn)

6. North America Europe and Australia Peanut Allergy Treatment Market, By Distribution Channel, 2026-2033, (USD Mn)

Introduction
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2020-2033
- Segment Trends
Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2033,(USD Mn)
Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2033,(USD Mn)
Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2033,(USD Mn)

7. North America Europe and Australia Peanut Allergy Treatment Market, By Region, 2026-2033, (USD Mn)

Introduction
- Market Share Analysis, By Region, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, For Regions, 2020-2031
- Regional Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2020-2033,(USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020-2033,(USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2033,(USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Countries, 2020-2033,(USD Mn)
  - U.S.
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2020-2033,(USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020-2033,(USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2033,(USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Sub-region, 2020-2033,(USD Mn)
Canada
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2020-2033,(USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020-2033,(USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2033,(USD Mn)
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2020-2033,(USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020-2033,(USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2033,(USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Countries, 2020-2033,(USD Mn)
  - U.K.
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2020-2033,(USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020-2033,(USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2033,(USD Mn)
Germany
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2020-2033,(USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020-2033,(USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2033,(USD Mn)
France
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2020-2033,(USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020-2033,(USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2033,(USD Mn)
Italy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2020-2033,(USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020-2033,(USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2033,(USD Mn)
Spain
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2020-2033,(USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020-2033,(USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2033,(USD Mn)
Russia
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2020-2033,(USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020-2033,(USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2033,(USD Mn)
Rest of Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2020-2033,(USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020-2033,(USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2033,(USD Mn)
Australia
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2020-2033,(USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020-2033,(USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2033,(USD Mn)

8. Competitive Landscape

Heat Map Analysis
Market Share Analysis
- DBV Technologies
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Aimmune Therapeutics, Inc.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Prota Therapeutics Pty Ltd
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- COUR Pharmaceuticals
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- BlueWillow Biologics
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- HAL Allergy B.V
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Allergy Therapeutics PLC
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Novartis AG
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Regeneron Pharmaceuticals, Inc.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Vedanta Biosciences, Inc
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Cambridge Allergy Ltd. (Camallergy)
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Angany Inc
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Moonlight Therapeutics Inc.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Moonlight Therapeutics Inc.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Allero Therapeutics B.V.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Sanofi
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Johnson & Johnson
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Viatris Inc. (Mylan N.V.)
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Sun Pharmaceutical Industries Ltd
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Bayer AG
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Aurobindo Pharma Limited.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Astellas Pharma Inc.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Astellas Pharma Inc.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Siolta Therapeutics
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- DESENTUM OY
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- ALK
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Immunomic Therapeutics, Inc.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Stallergenes Greer Ltd
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies

9. Section

Research Methodology
About Us and Services
Contact